5-HT1F receptor — Drug Target

All drugs that target 5-HT1F receptor — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

5-HT1F receptor agonist

Phase 3 pipeline (2)

• NP101 · NuPathe Inc. · 5-HT1F receptor agonist · Neurology
  NP101 is a selective serotonin 5-HT1F receptor agonist that reduces migraine pain by constricting cranial blood vessels and inhibiting neuropeptide release.
• BHV-4157 · Biohaven Therapeutics Ltd. · 5-HT1F receptor agonist · Neurology
  BHV-4157 is a selective serotonin 5-HT1F receptor agonist that reduces neuronal activity and neuropeptide release to treat acute migraine.